Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36
Bing Zhou, Lijing Jia, Zhijian Zhang, et al.
Advanced Science (2020) Vol. 7, Iss. 21
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Yanlin Wu, Zhengjun Lin, Changchun Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 188
Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA
Shengxi Jin, Peng Chen, Jing Yang, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 19
The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Ting Hong, Yiyan Chen, M Kellis, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 69
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 9
mTOR in metabolic homeostasis and disease
Xuejia Liu, Bin Guo, Qiye Li, et al.
Experimental Cell Research (2024) Vol. 441, Iss. 2, pp. 114173-114173
Closed Access | Times Cited: 8
Lipid Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism
Yu Bai, Yanyang Nan, Tao Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 6
Update on genetics and epigenetics in metabolic associated fatty liver disease
Xiaopeng Zhu, Mingfeng Xia, Xin Gao
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 25
Histone Modifications in NAFLD: Mechanisms and Potential Therapy
Yulei Shi, Wei Qi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14653-14653
Open Access | Times Cited: 12
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression
Z. X. Jiang, Qianlong Kang, Hong Qian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
CD36 in liver diseases
Yi Liu, Wenwei Yin
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access
Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatment
Yijing Li, Lijie Li, Yishuo Zhang, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access
C-C motif chemokines ligand 7 contributes to metabolic dysfunction-associated steatotic liver disease by enabling redox-sensitive induction of hypermethylated in cancer 1
Xinyue Sun, Jinge Wu, Heng Lv, et al.
Metabolism (2025), pp. 156242-156242
Closed Access
The effect of aldafermin expressing-Escherichia coli Nissle 1917 along with dietary change on visceral adipose tissue in MASLD mouse model
Valeria Iannone, Maija Vaittinen, Carlos Gómez-Gallego, et al.
International Journal of Obesity (2025)
Open Access
Discovery of novel ancestry specific genes for androgens and hypogonadism in Million Veteran Program Men
Meghana S. Pagadala, Craig C. Teerlink, Guneet K. Jasuja, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Epiberberine regulates lipid synthesis through SHP (NR0B2) to improve non-alcoholic steatohepatitis
Liming Zhou, Jinhua Fan, Xu Minmin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 4, pp. 166639-166639
Open Access | Times Cited: 10
Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver disease
Rong Gao, Jin Wang, Xuemin He, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 16
New Insights into the Diverse Functions of the NR2F Nuclear Orphan Receptor Family
Tajana Sajinovic, Gottfried Baier
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR‐CD36 axis
J Liu, Xinxin Zhang, Yufei Zhang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 7
Closed Access | Times Cited: 7
Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6
Victoria Klepsch, Kerstin Siegmund, Gottfried Baier
Cancers (2021) Vol. 13, Iss. 11, pp. 2600-2600
Open Access | Times Cited: 16
The multifaceted therapeutic value of targeting steroid receptor coactivator-1 in tumorigenesis
Qiang Chen, Peng Guo, Yilin Hong, et al.
Cell & Bioscience (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation
Jiaji Hu, Yigang Zheng, Hanglu Ying, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3796-3796
Open Access | Times Cited: 11
Micronized Palmitoylethanolamide Ameliorates Methionine- and Choline-Deficient Diet–Induced Nonalcoholic Steatohepatitis via Inhibiting Inflammation and Restoring Autophagy
Jiaji Hu, Hanglu Ying, Jie Yao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 14
Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: a retrospective cohort study
Ping Xu, Ye Zhu, Xinlu Ji, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Grpel2 maintains cardiomyocyte survival in diabetic cardiomyopathy through DLST-mediated mitochondrial dysfunction: a proof-of-concept study
Rongjin Yang, Xiaomeng Zhang, Yunyun Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top